Cognitive deficits in the N171-82Q transgenic mouse model of Huntington's disease

被引：0
|
作者：
Ramaswamy, S
McBride, JL
Herzog, C
Gasmi, M
Brandon, E
Bartus, R
Zhou, L
Berry-Kravis, E
Kodower, JH
机构：
[1] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA
[2] Ceregene Inc, San Diego, CA USA
来源：
EXPERIMENTAL NEUROLOGY | 2005年 / 193卷 / 01期
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：257 / 257
页数：1
相关论文
共 50 条
  • [41] Resveratrol protects against peripheral deficits in a mouse model of Huntington's disease
    Ho, Daniel J.
    Calingasan, Noel Y.
    Wille, Elizabeth
    Dumont, Magali
    Beal, M. Flint
    [J]. EXPERIMENTAL NEUROLOGY, 2010, 225 (01) : 74 - 84
  • [42] An Optimization of AAV-82Q-Delivered Rat Model of Huntington's Disease
    So, Kyoung-Ha
    Choi, Jai Ho
    Islam, Jaisan
    Elina, K. C.
    Moon, Hyeong Cheol
    Won, So Yoon
    Kim, Hyong Kyu
    Kim, Soochong
    Hyun, Sang-Hwan
    Park, Young Seok
    [J]. JOURNAL OF KOREAN NEUROSURGICAL SOCIETY, 2020, 63 (05) : 579 - 589
  • [43] Cognitive training modifies disease symptoms in a mouse model of Huntington's disease
    Yhnell, Emma
    Lelos, Mariah J.
    Dunnett, Stephen B.
    Brooks, Simon P.
    [J]. EXPERIMENTAL NEUROLOGY, 2016, 282 : 19 - 26
  • [44] Inhibition of endocannabinoid degradation rectifies motivational and dopaminergic deficits in the Q175 mouse model of Huntington’s disease
    Dan P. Covey
    Hannah M. Dantrassy
    Samantha E. Yohn
    Alberto Castro
    P. Jeffrey Conn
    Yolanda Mateo
    Joseph F. Cheer
    [J]. Neuropsychopharmacology, 2018, 43 : 2056 - 2063
  • [45] Inhibition of endocannabinoid degradation rectifies motivational and dopaminergic deficits in the Q175 mouse model of Huntington's disease
    Covey, Dan P.
    Dantrassy, Hannah M.
    Yohn, Samantha E.
    Castro, Alberto
    Conn, P. Jeffrey
    Mateo, Yolanda
    Cheer, Joseph F.
    [J]. NEUROPSYCHOPHARMACOLOGY, 2018, 43 (10) : 2056 - 2063
  • [46] COGNITIVE TRAINING IMPROVES DISEASE SYMPTOMS IN A MOUSE MODEL OF HUNTINGTON'S DISEASE
    Yhnell, Emma
    Lelos, Mariah
    Dunnett, Stephen
    Brooks, Simon
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2016, 87 : A100 - A100
  • [47] A fully humanized transgenic mouse model of Huntington disease
    Southwell, Amber L.
    Warby, Simon C.
    Carroll, Jeffrey B.
    Doty, Crystal N.
    Skotte, Niels H.
    Zhang, Weining
    Villanueva, Erika B.
    Kovalik, Vlad
    Xie, Yuanyun
    Pouladi, Mahmoud A.
    Collins, Jennifer A.
    Yang, X. William
    Franciosi, Sonia
    Hayden, Michael R.
    [J]. HUMAN MOLECULAR GENETICS, 2013, 22 (01) : 18 - 34
  • [48] Profiles of motor and cognitive impairment in the transgenic rat model of Huntington's disease
    Fielding, Steven A.
    Brooks, Simon P.
    Klein, Alexander
    Bayram-Weston, Zubeyde
    Jones, Lesley
    Dunnett, Stephen B.
    [J]. BRAIN RESEARCH BULLETIN, 2012, 88 (2-3) : 223 - 236
  • [49] Safety of Striatal Infusion of siRNA in a Transgenic Huntington's Disease Mouse Model
    Johnson, Emily
    Chase, Kathryn
    McGowan, Sarah
    Mondo, Erica
    Pfister, Edith
    Mick, Eric
    Friedline, Randall H.
    Kim, Jason K.
    Sapp, Ellen
    DiFiglia, Marian
    Aronin, Neil
    [J]. JOURNAL OF HUNTINGTONS DISEASE, 2015, 4 (03) : 219 - 229
  • [50] Progressive depletion of complexin II in a transgenic mouse model of Huntington's disease
    Morton, AJ
    Edwardson, JM
    [J]. JOURNAL OF NEUROCHEMISTRY, 2001, 76 (01) : 166 - 172
12345